Specifically, we previously identified two SHANK3 duplication patients who presented with hyperkinetic disorders, such as attention deficit hyperactivity disorder (ADHD) and bipolar disorder, and early-onset generalized tonic-clonic seizures [4]. This evidence concerns the gene SHANK3 and attention deficit-hyperactivity disorder.